Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Swain

Showing results (411-420 of 532) with videos related to

Pageof 54
Sort By:
Obesity Surgery|September 28, 2011
Nonalcoholic steatohepatitis (NASH) does not increase complications after laparoscopic bariatric surgeryToby N Weingarten, James M Swain, Michael L Kendrick, et al.
Virology|July 6, 2006
Complex adenovirus-vectored vaccine protects guinea pigs from three strains of Marburg virus challengesDanher Wang, Michael Hevey, Laure Y Juompan, et al.
The Lancet. Oncology|April 23, 2013
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 studySandra M Swain, Sung-Bae Kim, Javier Cortés, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 30, 2026
Exploring the Need for Plan Adaptation in Robustly Optimised Head and Neck Intensity Modulated Proton Therapy: A Dosimetric Perspective From Initial Institutional ExperienceV Raveendran, S Sinha, P Mukherjee, et al.
Cancer Medicine|May 2, 2013
Assessment of diagnosis of inflammatory breast cancer cases at two cancer centers in Egypt and TunisiaCatherine Schairer, Amr S Soliman, Sherif Omar, et al.
Frontiers in Oncology|September 28, 2020
Prevalence of Phosphatidylinositol-3-Kinase (PI3K) Pathway Alterations and Co-alteration of Other Molecular Markers in Breast CancerKatia Khoury, Antoinette R Tan, Andrew Elliott, et al.
The New England Journal of Medicine|February 19, 2015
Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancerSandra M Swain, José Baselga, Sung-Bae Kim, et al.
Journal of the National Cancer Institute|September 28, 2017
Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30Hanna Bandos, Joy Melnikow, Donna R Rivera, et al.
Prehospital Emergency Care|March 26, 2020
Control of Severe, Life-Threatening External Bleeding in the Out-of-Hospital Setting: A Systematic ReviewNathan P Charlton, Janel M Swain, Jan L Brozek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
Cardiac toxicity and efficacy of trastuzumab combined with pertuzumab in patients with [corrected] human epidermal growth factor receptor 2-positive metastatic breast cancerChia C Portera, Janice M Walshe, Douglas R Rosing, et al.
Pageof 54

Showing results (411-420 of 532) with videos related to

Sort By:
Pageof 54
Obesity Surgery|September 28, 2011
Nonalcoholic steatohepatitis (NASH) does not increase complications after laparoscopic bariatric surgeryToby N Weingarten, James M Swain, Michael L Kendrick, et al.
Virology|July 6, 2006
Complex adenovirus-vectored vaccine protects guinea pigs from three strains of Marburg virus challengesDanher Wang, Michael Hevey, Laure Y Juompan, et al.
The Lancet. Oncology|April 23, 2013
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 studySandra M Swain, Sung-Bae Kim, Javier Cortés, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 30, 2026
Exploring the Need for Plan Adaptation in Robustly Optimised Head and Neck Intensity Modulated Proton Therapy: A Dosimetric Perspective From Initial Institutional ExperienceV Raveendran, S Sinha, P Mukherjee, et al.
Cancer Medicine|May 2, 2013
Assessment of diagnosis of inflammatory breast cancer cases at two cancer centers in Egypt and TunisiaCatherine Schairer, Amr S Soliman, Sherif Omar, et al.
Frontiers in Oncology|September 28, 2020
Prevalence of Phosphatidylinositol-3-Kinase (PI3K) Pathway Alterations and Co-alteration of Other Molecular Markers in Breast CancerKatia Khoury, Antoinette R Tan, Andrew Elliott, et al.
The New England Journal of Medicine|February 19, 2015
Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancerSandra M Swain, José Baselga, Sung-Bae Kim, et al.
Journal of the National Cancer Institute|September 28, 2017
Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30Hanna Bandos, Joy Melnikow, Donna R Rivera, et al.
Prehospital Emergency Care|March 26, 2020
Control of Severe, Life-Threatening External Bleeding in the Out-of-Hospital Setting: A Systematic ReviewNathan P Charlton, Janel M Swain, Jan L Brozek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
Cardiac toxicity and efficacy of trastuzumab combined with pertuzumab in patients with [corrected] human epidermal growth factor receptor 2-positive metastatic breast cancerChia C Portera, Janice M Walshe, Douglas R Rosing, et al.
Pageof 54